Elisabeth A. Kastelijn

Author

Also Known As

E A Kastelijn, E. A. Elisabeth Kastelijn, E. A. Kastelijn, E.A. Kastelijn, ELISABETH A KASTELIJN, ELISABETH A. KASTELIJN, Elisabeth A (Lisanne) Kastelijn, Elisabeth A Kastelijn, Elisabeth A. Kastelijn, Elisabeth Anna Kastelijn

Publications

751

Citations

H-Index

Concepts

All Affiliations

St. Antonius Ziekenhuis University Medical Center Utrecht Radboud University Nijmegen Erasmus University Rotterdam Ziekenhuis Gelderse Vallei

About

Elisabeth A. Kastelijn is an author at St. Antonius Ziekenhuis specializing in medicine, oncology, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	385
2	Allergy	2	2	71
3	Public Health	1	1	77
4	Biostatistics	1	1	85
5	Epidemiology	1	1	77

Elisabeth A. Kastelijn

Publications

534

Citations

H-Index

Page 1

	Year	Citations
Diagnosing Non-Small Cell Lung Cancer by Exhaled Breath Profiling Using an Electronic Nose Sharina Kort, Marjolein Brusse‐Keizer, Hugo Schouwink, CHEST Journal AsthmaOncologyAdvanced Lung DiseaseCancer DetectionMedicine	2022	85
SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer Hossein Borghaei, Filippo de Marinis, Daphne W. Dumoulin, Annals of Oncology Nivolumab Versus DocetaxelMedicinePharmacologyAnti-cancer AgentPhase Iii Study	2023	78
Dutch Oncology COVID-19 consortium: Outcome of COVID-19 in patients with cancer in a nationwide cohort study Karlijn de Joode, Daphne W. Dumoulin, Jolien Tol, European Journal of Cancer EpidemiologyCancer EpidemiologyMedicineGlobal HealthCancer Management	2020	77
Polymorphisms in innate immunity genes associated with development of bronchiolitis obliterans after lung transplantation Elisabeth A. Kastelijn, Coline H.M. van Moorsel, Ger T. Rijkers, The Journal of Heart and Lung Transplantation Innate Immunity GenesAllergyInflammatory Lung DiseaseLung InflammationRespiratory Diseases	2010	50
Clinical Outcomes in Early-stage NSCLC Treated with Stereotactic Body Radiotherapy Versus Surgical Resection. Elisabeth A. Kastelijn, Sherif Y. El Sharouni, Frederik N Hofman, PubMed	2015	38
Cost-effectiveness of stereotactic body radiation therapy versus video assisted thoracic surgery in medically operable stage I non-small cell lung cancer: A modeling study Henri B. Wolff, Leonie Alberts, Naomi van der Linden, Lung Cancer	2020	36
Systemic and exhaled cytokine and chemokine profiles are associated with the development of bronchiolitis obliterans syndrome Elisabeth A. Kastelijn, Ger T. Rijkers, Coline H.M. van Moorsel, The Journal of Heart and Lung Transplantation InflammationChemokine ProfilesInflammatory Lung DiseaseLung InflammationRespiratory Diseases	2010	33
Differences in Longitudinal Health Utility between Stereotactic Body Radiation Therapy and Surgery in Stage I Non–Small Cell Lung Cancer Henri B. Wolff, Leonie Alberts, Elisabeth A. Kastelijn, Journal of Thoracic Oncology Longitudinal Health UtilityRadiation MedicineSurgical OncologyRadiation TherapyMedicine	2018	28
Evaluation of Serum Biomarker CEA and Ca-125 as Immunotherapy Response Predictors in Metastatic Non-small Cell Lung Cancer MAX R. CLEVERS, Elisabeth A. Kastelijn, Bas Peters, Anticancer Research	2021	28
Genetic polymorphisms in MMP7 and reduced serum levels associate with the development of bronchiolitis obliterans syndrome after lung transplantation Elisabeth A. Kastelijn, Coline HM van Moorsel, Henk J.T. Ruven, The Journal of Heart and Lung Transplantation TransplantationAllergyInflammatory Lung DiseaseLung InflammationGenetic Polymorphisms	2010	21

Page 1